Literature DB >> 24197551

Coexistence of renal artery stenosis, primary antiphospholipid syndrome and polycythaemia vera: an exceptional association.

F Zahra Ha-ou-Nou1, D Boumzebra, L Essaadouni.   

Abstract

Renal artery stenosis is the narrowing of the renal artery which causes hypertension and atrophy of the affected kidney, ultimately leading to renal failure if not treated and most often caused by atherosclerosis or fibromuscular dysplasia. Recently, renal artery stenosis has also been documented in patients with the antiphospholipid syndrome and in very few cases with myeloproliferative disease. In this paper, we describe a 31-year-old female with a history of gangrene affecting the toes with severe hypertension (200/110 mmHg), whose investigations revealed a combination of renal artery stenosis, primary antiphospholipid syndrome and polycythaemia vera.

Entities:  

Keywords:  Hughes syndrome; Renal artery stenosis; antiphospholipid syndrome; polycythaemia vera

Mesh:

Year:  2013        PMID: 24197551     DOI: 10.1177/0961203313512010

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

Review 1.  Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review.

Authors:  Eikan Mishima; Takehiro Suzuki; Yoichi Takeuchi; Kazumasa Seiji; Noriko Fukuhara; Kei Takase; Hideo Harigae; Takaaki Abe; Sadayoshi Ito
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738

2.  Possible interesting link between Janus kinase 2 mutation and renovascular hypertension.

Authors:  Kouichi Tamura; Kotaro Haruhara; Kengo Azushima; Tamio Iwamoto; Hiromichi Wakui
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738

3.  Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms.

Authors:  Raunak Rao; Spoorthy Kulkarni; Ian B Wilkinson
Journal:  Case Rep Vasc Med       Date:  2020-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.